WILSONS Maintains Mayne Pharma Group (ASX:MYX) Overweight Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on August 30, 2023, WILSONS maintained coverage of Mayne Pharma Group (ASX:MYX) with a Overweight recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-922709040-0fe866fda18e43b6b27080af00276243.jpg "5 Alternatives to Starting Your Own Business")
:max_bytes(150000):strip_icc():format(jpeg)/layoff-5817f3dc5f9b581c0be5100f.jpg "Furlough vs. Layoff")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1456438577-e679cb9e253347f0bf3b37e249b55660.jpg "What a 5 Million House Really Costs")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-942149588-c1f08ddba9c4491eb02bd6c1a76b0117.jpg "How to Cope with 10 Coworker Personality Types")